Font Size
A
A
A

Kidney Disease: Iron Therapy


Topic Overview

A decrease in the number of circulating blood cells (anemia) is a common problem in people who have chronic kidney disease. It is often caused by a decrease in the amount of a protein produced by the kidneys (erythropoietin).

Some people who receive man-made erythropoietin (rhEPO therapy) continue to have anemia because of low levels of iron in their blood. These people are usually given extra iron to help treat this problem. Intravenous (IV) iron may be needed if oral iron does not increase iron levels. IV iron can also be used to treat anemia that occurs during hemodialysis.

Related Information

Credits

ByHealthwise Staff
Primary Medical ReviewerAnne C. Poinier, MD - Internal Medicine
Specialist Medical ReviewerMitchell H. Rosner, MD - Nephrology
Last RevisedSeptember 15, 2011

eMedicineHealth Medical Reference from Healthwise

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.





Medical Dictionary